CoChat

Resting energy expenditure in children at risk of hypothalamic dysfunction

Van Schaik, J, Burghard, M, Lequin, M H, van Maren, E A, van Dijk, A M, Takken, T, Rehorst-Kleinlugtenbelt, L B, Bakker, B, Meijer, L, Hoving, E W, Fiocco, M, Schouten-van Meeteren, A Y N, Tissing, W J E, van Santen, H M · 2022 · Endocrine Connections
Cited by 13

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: Children with suprasellar brain damage are at risk of hypothalamic dysfunction (HD). HD may lead to decreased resting energy expenditure (REE). Decreased REE, however, is not present in all children with HD. Our aim was to assess which children suspect for HD have low REE, and its association with clinical severity of HD or radiological hypothalamic damage. Patients and methods: A retrospective cohort study was performed. Measured REE (mREE) of children at risk of HD was compared to predicted REE (pREE). Low REE was defined as mREE <90% of predicted. The mREE/pREE quotient was associated to a clinical score for HD symptoms and to radiological hypothalamic damage. Results: In total, 67 children at risk of HD (96% brain tumor diagnosis) with a mean BMI SDS of +2.3 ± 1.0 were included. Of these, 45 (67.2%) had low mREE. Children with severe HD had a significant lower mean mREE/pREE quotient compared to children with no, mild, or moderate HD. Mean mREE/pREE quotient of children with posterior hypothalamic damage was significantly lower compared to children with no or anterior damage. Tumor progression or tumor recurrence, severe clinical HD, and panhypopituitarism with diabetes insipidus (DI) were significant risk factors for reduced REE. Conclusion: REE may be lowered in children with hypothalamic damage and is associated to the degree of clinical HD. REE is, however, not lowered in all children suspect for HD. For children with mild or moderate clinical HD symptoms, REE measurements may be useful to distinguish between those who may benefit from obesity treatment that increases REE from those who would be better helped using other obesity interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/ec-22-0276

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Roth CLHypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Frontiers in Endocrinology20112 49. (https://doi.org/10.3389/fendo.2011.00049)22654811 · doi:10.3389/fendo.2011.00049)22654811
  2. Muller HLCraniopharyngioma. Endocrine Reviews201435513–543. (https://doi.org/10.1210/er.2013-1115)10.1210/er.2013-111521846381 · DOI · Paper page
  3. Iughetti LBruzzi P. Obesity and craniopharyngioma. Italian Journal of Pediatrics201137 38. (https://doi.org/10.1186/1824-7288-37-38)22654817 · doi:10.1186/1824-7288-37-38)22654817
  4. Lustig RHHypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Frontiers in Endocrinology20112 60. (https://doi.org/10.3389/fendo.2011.00060)26124708 · doi:10.3389/fendo.2011.00060)26124708
  5. van Iersel LBrokke KEAdan RAHBulthuis LCMvan den Akker ELTvan Santen HM. Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocrine Reviews201940193–235. (https://doi.org/10.1210/er.2018-00017)10.1210/er.2018-0001726973721 · DOI · Paper page
  6. Castro DCCole SLBerridge KC. Lateral hypothalamus, nucleus accumbens, and ventral pallidum roles in eating and hunger: interactions between homeostatic and reward circuitry. Frontiers in Systems Neuroscience20159 90. (https://doi.org/10.3389/fnsys.2015.00090) · DOI · Paper page
  7. Ness KKMorris EBNolan VGHowell CRGilchrist LSStovall MCox CLKlosky JLGajjar ANeglia JP. Physical performance limitations among adult survivors of childhood brain tumors. Cancer20101163034–3044. (https://doi.org/10.1002/cncr.25051)10.1002/cncr.2505126203601 · DOI · Paper page
  8. Zhang FFSaltzman EMust AParsons SK. Do childhood cancer survivors meet the diet and physical activity guidelines? A review of guidelines and literature. International Journal of Child Health and Nutrition2012144–58. (https://doi.org/10.6000/1929-4247.2012.01.01.06) · DOI · Paper page
  9. Stolley MRRestrepo JSharp LK. Diet and physical activity in childhood cancer survivors: a review of the literature. Annals of Behavioral Medicine201039232–249. (https://doi.org/10.1007/s12160-010-9192-6)10.1007/s12160-010-9192-616562585 · DOI · Paper page
  10. Rose SREndocrinopathies in childhood cancer survivors. Endocrinologist200313488–495. (https://doi.org/10.1097/01.ten.0000098611.49230.10)10.1097/01.ten.0000098611.49230.1022649386 · DOI
  11. Crenn PHamchaoui SBourget-Massari AHanachi MMelchior JCAzouvi P. Changes in weight after traumatic brain injury in adult patients: a longitudinal study. Clinical Nutrition201433348–353. (https://doi.org/10.1016/j.clnu.2013.06.003)10.1016/j.clnu.2013.06.003 · DOI
  12. Thompson CJCostello RWCrowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clinical Endocrinology201990506–516. (https://doi.org/10.1111/cen.13929)10.1111/cen.13929 · DOI · Paper page
  13. Holmer HPozarek GWirfalt EPopovic VEkman BBjork JErfurth EM. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. Journal of Clinical Endocrinology and Metabolism2010955395–5402. (https://doi.org/10.1210/jc.2010-0993)10.1210/jc.2010-0993 · DOI · Paper page
  14. Lustig RHHypothalamic obesity: the sixth cranial endocrinopathy. Endocrinologist200212210–217. (https://doi.org/10.1097/00019616-200205000-00008)10.1097/00019616-200205000-00008 · DOI · Paper page
  15. Gupta RDRamachandran RVenkatesan PAnoop SJoseph MThomas N. Indirect calorimetry: from bench to bedside. Indian Journal of Endocrinology and Metabolism201721594–599. (https://doi.org/10.4103/ijem.IJEM_484_16)10.4103/ijem.IJEM_484_16 · DOI · Paper page
  16. Bomer ISaure CCaminiti CRamos JGZuccaro GBrea MBravo MMaza C. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. Journal of Pediatric Endocrinology and Metabolism2015281305–1312. (https://doi.org/10.1515/jpem-2015-0167)25431867 · doi:10.1515/jpem-2015-0167)25431867
  17. Puget SGarnett MWray AGrill JHabrand JLBodaert NZerah MBezerra MRenier DPierre-Kahn APediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. Journal of Neurosurgery2007106 (1Supplement) 3–12. (https://doi.org/10.3171/ped.2007.106.1.3)25381948 · doi:10.3171/ped.2007.106.1.3)25381948
  18. Muller HLGebhardt UTeske CFaldum AZwiener IWarmuth-Metz MPietsch TPohl FSorensen NCalaminus GPost-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. European Journal of Endocrinology201116517–24. (https://doi.org/10.1530/EJE-11-0158)10.1530/EJE-11-015822654811 · DOI · Paper page
  19. Mason PWKrawiecki NMeacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Archives of Pediatrics and Adolescent Medicine2002156887–892. (https://doi.org/10.1001/archpedi.156.9.887)10.1001/archpedi.156.9.88721846381 · DOI · Paper page
  20. Ismail DO'Connell MAZacharin MR. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. Journal of Pediatric Endocrinology and Metabolism200619129–134. (https://doi.org/10.1515/jpem.2006.19.2.129)22654817 · doi:10.1515/jpem.2006.19.2.129)22654817
  21. Elfers CTRoth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Frontiers in Endocrinology20112 78. (https://doi.org/10.3389/fendo.2011.00078)26124708 · doi:10.3389/fendo.2011.00078)26124708
  22. Denzer CDenzer FLennerz BSVollbach HLustig RHWabitsch M. Treatment of hypothalamic obesity with dextroamphetamine: a case series. Obesity Facts20191291–102. (https://doi.org/10.1159/000495851)10.1159/000495851 · DOI · Paper page
  23. Ashcraft CMFrankenfield DC. Validity test of a new open-circuit indirect calorimeter. Journal of Parenteral and Enteral Nutrition201539738–742. (https://doi.org/10.1177/0148607114526242)10.1177/014860711452624226203601 · DOI
  24. Robles-Gonzalez LGutierrez-Hellin JAguilar-Navarro MRuiz-Moreno CMunoz ADel-Coso JRuiz JRAmaro-Gahete FJ. Inter-day reliability of resting metabolic rate and maximal fat oxidation during exercise in healthy men using the Ergostik gas analyzer. Nutrients2021134308. (https://doi.org/10.3390/nu13124308)10.3390/nu13124308 · DOI
  25. Oshima TDupertuis YMDelsoglio MGraf SHeidegger CPPichard C. In vitro validation of indirect calorimetry device developed for the ICALIC project against mass spectrometry. Clinical Nutrition ESPEN20193250–55. (https://doi.org/10.1016/j.clnesp.2019.05.004)10.1016/j.clnesp.2019.05.00416562585 · DOI
  26. Delsoglio MDupertuis YMOshima Tvan der Plas MPichard C. Evaluation of the accuracy and precision of a new generation indirect calorimeter in canopy dilution mode. Clinical Nutrition2020391927–1934. (https://doi.org/10.1016/j.clnu.2019.08.017)10.1016/j.clnu.2019.08.01722649386 · DOI
  27. Weir JBNew methods for calculating metabolic rate with special reference to protein metabolism. Journal of Physiology19491091–9. (https://doi.org/10.1113/jphysiol.1949.sp004363)10.1113/jphysiol.1949.sp004363 · DOI · Paper page
  28. Blond EMaitrepierre CNormand SSothier MRoth HGoudable JLaville M. A new indirect calorimeter is accurate and reliable for measuring basal energy expenditure, thermic effect of food and substrate oxidation in obese and healthy subjects. e-SPEN20116e7–e15. (https://doi.org/10.1016/j.eclnm.2010.12.001)10.1016/j.eclnm.2010.12.001 · DOI
  29. Lindman HWiklund THolte HLjungman PBlomqvist CKvalheim GBengtsson MHoglund MWilking NBergh J. FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study Group. Acta Oncologica199938239–245. (https://doi.org/10.1080/028418699431672)17591624 · doi:10.1080/028418699431672)17591624
  30. Cole TJBellizzi MCFlegal KMDietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ20003201240–1243. (https://doi.org/10.1136/bmj.320.7244.1240)10.1136/bmj.320.7244.1240 · DOI · Paper page
  31. Cole TJFlegal KMNicholls DJackson AA. Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ2007335 194. (https://doi.org/10.1136/bmj.39238.399444.55) · DOI · Paper page
  32. Schofield WNPredicting basal metabolic rate, new standards and review of previous work. Human Nutrition: Clinical Nutrition198539 (Supplement 1) 5–41.
  33. Henry CJKDyer SGhusain-Choueiri A. New equations to estimate basal metabolic rate in children aged 10–15 years. European Journal of Clinical Nutrition199953134–142. (https://doi.org/10.1038/sj.ejcn.1600690)10.1038/sj.ejcn.160069025381948 · DOI
  34. Lazzer SAgosti FDe Col ASartorio A. Development and cross-validation of prediction equations for estimating resting energy expenditure in severely obese Caucasian children and adolescents. British Journal of Nutrition200696973–979. (https://doi.org/10.1017/bjn20061941)10.1017/BJN20061941 · DOI · Paper page
  35. Molnar DJeges SErhardt ESchutz Y. Measured and predicted resting metabolic-rate in obese and nonobese adolescents. Journal of Pediatrics1995127571–577. (https://doi.org/10.1016/s0022-3476(9570114-1)10.1016/S0022-3476(95)70114-1 · DOI
  36. Schmelzle HSchroder CArmbrust SUnverzagt SFusch C. Resting energy expenditure in obese children aged 4 to 15 years: measured versus predicted data. Acta Paediatrica200493739–746. (https://doi.org/10.1111/j.1651-2227.2004.tb01000.x)10.1111/j.1651-2227.2004.tb01000.x · DOI
  37. De Vile CJGrant DBKendall BENeville BGStanhope RWatkins KEHayward RD. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?Journal of Neurosurgery19968573–81. (https://doi.org/10.3171/jns.1996.85.1.0073)10.3171/jns.1996.85.1.0073 · DOI · Paper page
  38. Mortini PGagliardi FBailo MSpina AParlangeli AFalini ALosa M. Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas. Endocrine201651148–162. (https://doi.org/10.1007/s12020-015-0683-x)10.1007/s12020-015-0683-x · DOI
  39. Caminiti CSaure CBomer IBrea MGonzalez Ramos J. Nutritional assessment of a population with a history of childhood craniopharyngioma seen at Hospital ‘Prof. Dr. Juan P. Garrahan’. Archivos Argentinos de Pediatria201711543–49. (https://doi.org/10.5546/aap.2017.eng.43) · DOI
  40. Kim RJShah RTershakovec AMZemel BSSutton LNGrimberg AMoshang T. Energy expenditure in obesity associated with craniopharyngioma. Child’s Nervous System201026913–917. (https://doi.org/10.1007/s00381-009-1078-1)10.1007/s00381-009-1078-1 · DOI · Paper page
  41. Simoneau-Roy JO'Gorman CPencharz PAdeli KDaneman DHamilton J. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clinical Endocrinology201072364–370. (https://doi.org/10.1111/j.1365-2265.2009.03639.x)10.1111/j.1365-2265.2009.03639.x · DOI · Paper page
  42. Cohen MSyme CMcCrindle BWHamilton J. Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity. European Journal of Endocrinology2013168845–852. (https://doi.org/10.1530/EJE-12-1082)10.1530/EJE-12-1082 · DOI · Paper page
  43. Hong ARLee MLee JHKim JHKim YHChoi HJ. Clinical implication of individually tailored segmentation method for distorted hypothalamus in craniopharyngioma. Frontiers in Endocrinology202112763523. (https://doi.org/10.3389/fendo.2021.763523)10.3389/fendo.2021.763523 · DOI
  44. Fjalldal SFollin CGabery SSundgren PCBjorkman-Burtscher IMLatt JMannfolk PNordstrom CHRylander LEkman BDetailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. International Journal of Obesity201943533–544. (https://doi.org/10.1038/s41366-018-0185-z)10.1038/s41366-018-0185-z · DOI
  45. Skorzewska ALal SWaserman JGuyda H. Abnormal food-seeking behavior after surgery for craniopharyngioma. Neuropsychobiology19892117–20. (https://doi.org/10.1159/000118545)10.1159/000118545 · DOI · Paper page
  46. Rakhshani NJeffery ASSchulte FBarrera MAtenafu EGHamilton JK. Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity. Obesity2010181768–1774. (https://doi.org/10.1038/oby.2009.491)10.1038/oby.2009.491 · DOI · Paper page
  47. Steele CACuthbertson DJMacFarlane IAJavadpour MDas KSVGilkes CWilding JPDaousi C. Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic. European Journal of Endocrinology2013168501–507. (https://doi.org/10.1530/EJE-12-0792)10.1530/EJE-12-0792 · DOI
  48. Sterkenburg ASHoffmann AGebhardt UWaldeck ESpringer SMuller HL. Childhood craniopharyngioma with hypothalamic obesity – no long-term weight reduction due to rehabilitation programs. Klinische Padiatrie2014226344–350. (https://doi.org/10.1055/s-0034-1387747) · DOI · Paper page
  49. Meijneke RWHSchouten-van Meeteren AYNde Boer NYVan Zundert Svan Trotsenburg PASStoelinga Fvan Santen HM. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment. Journal of Pediatric Endocrinology and Metabolism20152859–63. (https://doi.org/10.1515/jpem-2014-0338) · DOI · Paper page
  50. Geffner MLundberg MKoltowska-Haggstrom MAbs RVerhelst JErfurth EMKendall-Taylor PPrice DAJonsson PBakker B. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). Journal of Clinical Endocrinology and Metabolism2004895435–5440. (https://doi.org/10.1210/jc.2004-0667)10.1210/jc.2004-0667 · DOI · Paper page
  51. Chima LMulrooney HMWarren JMadden AM. A systematic review and quantitative analysis of resting energy expenditure prediction equations in healthy overweight and obese children and adolescents. Journal of Human Nutrition and Dietetics202033373–385. (https://doi.org/10.1111/jhn.12735)10.1111/jhn.12735 · DOI

Cited by

See all 13

Metadata

Authors
Van Schaik, J., Burghard, M., Lequin, M. H., van Maren, E. A., van Dijk, A. M., Takken, T., Rehorst-Kleinlugtenbelt, L. B., Bakker, B., Meijer, L., Hoving, E. W., Fiocco, M., Schouten-van Meeteren, A. Y. N., Tissing, W. J. E., & van Santen, H. M.
Affiliations
  • Division of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
  • Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
  • Department of Dietetics, University Medical Center Utrecht, Utrecht, The Netherlands
  • Division of Neurosurgery, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Venue
Endocrine Connections
Published
2022-08-01
Volume
11
Issue
8
ISSN
2049-3614
Cited by
13
References
10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.